| 1 |
32061245 | Incidence and predictors of nevirapine and efavirenz-associated rash among Indonesian HIV patients. | 2022 Jun |
2 |
| 2 |
35484635 | Trough plasma nevirapine levels, immunologic and virologic responses in composite CYP2B6*6/*18 HIV-infected adult Nigerian patients. | 2022 Jul |
1 |
| 3 |
33312265 | On a Shape-Invariant Hazard Regression Model with application to an HIV Prevention Study of Mother-to-Child Transmission. | 2020 Dec |
1 |
| 4 |
30532754 | Myeloid Cells in Intact Human Cervical Explants Capture HIV and Can Transmit It to CD4 T Cells. | 2018 |
1 |
| 5 |
26867536 | Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa. | 2016 Feb 11 |
1 |
| 6 |
25992639 | Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. | 2015 |
1 |
| 7 |
26348712 | Effects of CYP2B6 and CYP1A2 Genetic Variation on Nevirapine Plasma Concentration and Pharmacodynamics as Measured by CD4 Cell Count in Zimbabwean HIV-Infected Patients. | 2015 Sep |
1 |
| 8 |
24521425 | Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment. | 2014 Feb 12 |
1 |
| 9 |
24708626 | The impact of HBV or HCV infection in a cohort of HIV-infected pregnant women receiving a nevirapine-based antiretroviral regimen in Malawi. | 2014 Apr 4 |
1 |
| 10 |
25312984 | Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan. | 2014 Dec |
1 |
| 11 |
22997212 | Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission. | 2013 Jan |
1 |
| 12 |
22082652 | Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS. | 2012 Jan |
2 |
| 13 |
23781668 | Prevention of perinatal HIV I transmission by protease inhibitor based triple drug antiretroviral therapy versus nevirapine as single dose at the time of delivery. | 2012 Dec |
1 |
| 14 |
21199294 | CD4+ cell count and risk for antiretroviral drug resistance among women using peripartum nevirapine for perinatal HIV prevention. | 2011 Mar |
1 |
| 15 |
21330912 | Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count. | 2011 Mar 27 |
1 |
| 16 |
21810746 | Genome-wide association study identifies variations in 6p21.3 associated with nevirapine-induced rash. | 2011 Aug |
1 |
| 17 |
21819809 | [Modeling of antiretroviral response from taxonomy of CD4 cells count trajectories in profound immunodeficiency setting]. | 2011 May-Jun |
1 |
| 18 |
23637509 | CD4(+) T Cell Response to Lamivudine, Stavudine and Nevirapine in Human Immunodeficiency Virus Infected Antiretroviral-Naive Men in Nigeria. | 2011 Dec |
1 |
| 19 |
20136661 | Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts. | 2010 May |
1 |
| 20 |
20193053 | Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon. | 2010 Mar 1 |
1 |
| 21 |
20236364 | Prevalence of mutations and determinants of genotypic resistance to etravirine (TMC125) in a large Italian resistance database (ARCA). | 2010 Sep |
1 |
| 22 |
20395870 | Associations with virologic treatment failure in adults on antiretroviral therapy in South Africa. | 2010 Aug |
1 |
| 23 |
20400407 | Liver toxicity after switching or simplifying to nevirapine-based therapy is not related to CD4 cell counts: results of the TOSCANA study. | 2010 Jan-Feb |
1 |
| 24 |
20576111 | Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire. | 2010 Jun 24 |
1 |
| 25 |
19925403 | Long-term effectiveness and safety outcomes in HIV-1-infected patients after a median time of 6 years on nevirapine. | 2009 Sep |
1 |
| 26 |
20079166 | Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study. | 2009 Oct 20 |
1 |
| 27 |
18199168 | Risk of side effects associated with the use of nevirapine in treatment-naïve patients, with respect to gender and CD4 cell count. | 2008 Jan |
1 |
| 28 |
18389979 | Incidence and risk factors of nevirapine-associated severe hepatitis among HIV-infected patients with CD4 cell counts less than 250 cells/microL. | 2008 Feb |
1 |
| 29 |
18615121 | Risk for immune-mediated liver reactions by nevirapine revisited. | 2008 Apr-Jun |
1 |
| 30 |
17259905 | Antiretroviral-associated toxicity among HIV-1-seropositive pregnant women in Mozambique receiving nevirapine-based regimens. | 2007 Apr 1 |
4 |
| 31 |
17591022 | Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts. | 2007 |
1 |
| 32 |
17704685 | Safety of switching to nevirapine-based highly active antiretroviral therapy at elevated CD4 cell counts in a resource-constrained setting. | 2007 Aug 15 |
1 |
| 33 |
18035868 | Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients. | 2007 |
2 |
| 34 |
16556085 | Controversies in the use of nevirapine for prevention of mother-to-child transmission of HIV. | 2006 Apr |
1 |
| 35 |
16630038 | Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy. | 2006 May |
1 |
| 36 |
16734954 | Nevirapine toxicity. | 2006 Jun |
1 |
| 37 |
16752931 | Treating HIV during pregnancy: an update on safety issues. | 2006 |
1 |
| 38 |
16945080 | Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women. | 2006 Jul |
1 |
| 39 |
17319344 | The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience. | 2006 Dec |
1 |
| 40 |
15764851 | The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART. | 2005 Mar 25 |
1 |
| 41 |
16156884 | A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load. | 2005 Sep |
1 |
| 42 |
16359170 | Evidence of an immune-mediated mechanism for an idiosyncratic nevirapine-induced reaction in the female Brown Norway rat. | 2005 Dec |
2 |
| 43 |
15012645 | Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy. | 2004 Mar |
1 |
| 44 |
15090798 | Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load. | 2004 Feb 20 |
1 |
| 45 |
15167296 | Immune status and uptake of antiretroviral interventions to prevent mother-to-child transmission of HIV-1 in Africa. | 2004 Jun 1 |
2 |
| 46 |
15280785 | Nevirapine-containing regimens in HIV-infected naive patients with CD4 cell counts of 200 cells/microl or less. | 2004 Aug 20 |
3 |
| 47 |
12689413 | Bystander CD4+ T lymphocytes survive in HIV-infected human lymphoid tissue. | 2003 Mar |
1 |
| 48 |
12700448 | A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients. | 2003 May 2 |
1 |
| 49 |
12916010 | Sustained efficacy of nevirapine in combination with two nucleoside analogues in the treatment of HIV-infected patients: a 48-week retrospective multicenter study. | 2003 Jul-Aug |
1 |
| 50 |
14562857 | Efficacy and durability of nevirapine in antiretroviral drug näive patients. | 2003 Sep |
1 |